Overview for In the news

High prevalence of adverse effects with active buprenorphine use in care home residents living with dementia

Buprenorphine transdermal system is increasingly prescribed for people with advanced dementia. However, little is known about the potential adverse effects, such as nausea, sedation, or confusion, in people living with moderate to severe dementia and depressive symptoms in care homes.

This gap was addressed by the DEP.PAIN.DEM trial, which was funded by the Research Council of Norway and conducted by the Centre for Elderly and Nursing Home Medicine, University of Bergen.

Written by Lakshini Mendis on Tuesday May 29, 2018
Category: In the news - Tags: carehomeresearch, alzheimers, pain, medication